IMVT

IMMUNOVANT INC

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary

IMMUNOVANT INC (IMVT) is held as common stock by 6 tracked hedge-fund managers, with a combined reported value of ~$259.62M; the largest are Baker Bros. Advisors, Renaissance Technologies, Izzy Englander. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 3 new, 2 added. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.

Attention · MediumThis quarter · Heating up

Common-stock holders61 also report options

Congress trades0

Price$33.49vs quarter-end-13.08%

Sectors0

This quarter's moves

New3

Added2

Trimmed / sold0

Top holderBaker Bros. Advisors

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Baker Bros. AdvisorsHold

Value $209.42M1.1% of portfolio5,435,2202026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Baker Bros. Advisors	2026 Q2	$209.42M	5,435,220	1.1%	Hold

PUT / CALL disclosures

Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.

Ken GriffinPUT—

Value $2.60M— of portfolio67,4002026 Q2

Ken GriffinCALL—

Value $2.23M— of portfolio57,8002026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Ken GriffinPUT	2026 Q2	$2.60M	67,400	—	—
Ken GriffinCALL	2026 Q2	$2.23M	57,800	—	—

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.